MAFG and hepatocellular carcinoma: This study is advantaged at the identification and validation of a novel 2-TF signature consisted of HMGA1 and MAFG, which is able to predict the prognosis and therapeutic response of HCC via distinguishing the characteristics of tumor proliferation and metabolism.